With the powerful support of China’s policies, rapid progress has been made in stem-cell industry, which has involved collection and storage of stem cells(upstream), preparation of stem cells and drug R&D(midstream), clinical trials of stem cells(downstream). Under the development during nearly 20 years, there have been nearly 100 companies with various scales in China engaged in technology R&D, establishment of stem cell banks and application of stem cells. China’s market of stem cells is expected to reach RMB 150 billion by 2020.

    However, compared with other countries, development of stem cells in China needs to be accelerated. Besides focusing on major scientific issues and bottlenecks, we should also strive to make breakthroughs of scientific theories and core technologies in the fields where China takes the lead, so as to promote the clinical translation.

    This conference is one of the top-ranked meetings in the field of stem cells in China. Through participating in it, you can learn more about the processing of technologies, the whole industry and the market of stem cells, stem cell bank, stem cell reprogramming, stem cell clinical organoids in China. Welcome to this academic banquet! Bioon will try our best to provide an excellent platform for you to communicate with China's first-class experts and senior managers, as well as to expand your business in China!